PharmaShots | Incisive News in 3 Shots

Subscribe Now

PD-L1-Positive

Roche's Tecentriq (atezolizumab) + Abraxane Receive European Commission's Approval for Patients with PD-L1-Positive Metastatic Triple-Negative Breast Cancer

Roche's Tecentriq (atezolizumab) + Abraxane Receive European Commission's Approval for Patients with PD-L1-Positive Metastatic Tri...

August 29, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us